Pharma's Twitter KLOUT

Twitter, for all intents and purposes, is arguably the hottest new tool to hit the social media scene since well.....errrrrrr....Facebook (are there really any others?). That said, everyone who is anybody has jumped on the Twitter bandwagon whether or not using Twitter has any positive or negative effects for its users. Nevertheless, insightful social media analysts like Mark Senak, author of the fabulous EyeonFDA blog, frequently attempt to assess the overall effectiveness of social media tools like Twitter on specific industries—in this case, the life sciences industry.

To make sense of the relative effectiveness (influence) of Twitter use by life sciences companies, Mark used a Twitter and Facebook assessment tool known as KLOUT.  KLOUT generates a “score” for individual Twitter feeds based on a combination of 35 different variables. The resultant scores fall into a range from 1-100 with a higher score indicating a wider range of influence. 

Not surprisingly, Mark’s analysis revealed that Twitter feeds sponsored by Roche (Roche News, 52), Novartis (Novartis, 52) and Pfizer (Pfizer News, 51), three of the world’s largest pharmaceutical companies had the most KLOUT. Not far behind were Lilly (Lillypad, 47), Pfizer (PfizerMexico), AstraZeneca (AstraZeneca, 45) and Amgen (Amgen, 44). Other companies that warrant honorable mention include: Genentech (GenentechNews, 40), Bristol-Myers Squibb (BMSNews, 40), Johnson & Johnson (JNJStories, 40) and Vertex Pharmaceuticals (VertexPharma, 39).

Interestingly, many companies sponsor multiple Twitter feeds. For example, Sanofi Aventis AstraZeneca, Bayer, Boehringer Ingelheim and Novartis have five, JNJ has 4 and Roche, Baxter and Amgen have 3. It isn’t clear to me why companies would want to have more than one Twitter feed; doesn’t that dilute corporate messaging? But, then again, what do I know?  I am not a marketing or PR guy!

So, what does this all mean? As far as I can tell—not much! The only conclusion that I can draw from all of this is that Twitter, the most recent successful addition to the social media armamentarium, is no longer new but here to stay!

Until next time...

Good Luck and Good Tweeting!!!!!!!

 

A Job Loss Score Card for You

I know this is kind of odd, but I have recently begun to wonder which life sciences companies have layed off the most employees this past year. Well, for those of you out there who were also wondering we don't have to wonder any longer because Ed Silverman over at the Pharmalot blog has conveniently compiled a list of the top offenders for us. For those of you who may be wondering which company was number one on the list, it’s name begins with a “P” and ends with an “r.”


Until next time…


Good Luck and Good Job Hunting!!!!!!!!
 

Pharmaceutical Industry is Losing its Reputation As an Ethical Industry

According to a recent analysis conducted by Covalence a Geneva Switzerland-based organization that tracks the ethical reputation of multinationals, the pharmaceutical industry’s ethical reputation dropped from first to third on Covalence’s all-time EthicalQuote ranking that monitors 10 industries. Further, over the past year, pharma has only managed to achieve an overall ranking of 8th on the list.

The reasons given for the ongoing decline are increased attention on product risk and decreasing media coverage of donations and philanthropy of pharmaceutical companies. The recent high profile coverage of the safety risks associated GlaxoSmithKline’s Paxil and Merck’s Vioxx are good examples of why the ethical image of pharma continues on its downward spiral.

To improve their image, ethicists recommend that drug companies showcase innovative drugs in poor countries, reduce prices to increase access to drugs and loosen intellectual property rights so that there is global access to potentially life-saving drugs. While several companies like Merck and Roche have gone down this path, it may be too little too late.

Until next time…

Good Luck and Good Job Hunting!!!!!!!!